BZL101

DRUG2 trials

Sponsors

Bionovo

Conditions

Metastatic Breast Cancer

Phase 1

A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

CompletedNCT00454532

BionovoMetastatic Breast Cancer

Start: 2007-03-31Updated: 2012-03-16

Phase 2

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

BionovoMetastatic Breast Cancer

Start: 2012-01-31End: 2015-07-31Target: 80Updated: 2012-02-08